SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-102167
Filing Date
2019-04-10
Accepted
2019-04-10 06:05:02
Documents
2
Effectiveness Date
2019-04-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A d695162ddefa14a.htm DEFA14A 39402
2 GRAPHIC g695162g0410040431730.jpg GRAPHIC 2703
  Complete submission text file 0001193125-19-102167.txt   44337
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36407 | Film No.: 19740488
SIC: 2834 Pharmaceutical Preparations